Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant ...

The mucus is a common symptom in chronic lung diseases such as COPD ( chronic bronchitis and emphysema), cystic fibrosis, bronchiectasis, NTM lung disease, or asthma. Besides ailments related to lungs ...

Tuberculosis (TB)is a formidable adversary in the realm of infectious diseases, one that has plagued humanity for centuries.

Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Insmed (INSM – Research Report) yesterday and set a price target ...

Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on INSM stock, giving a Buy rating on November 8.Don't Miss our ...

Insmed’s first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United ...

Professor Kornberg, who was awarded the Nobel Prize in Chemistry in 2006 for his groundbreaking work in molecular biology, is a renowned leader in the field of eukaryotic gene transcription. His ...

The odds of beating lung cancer are increasingly good as time goes on,” said Dr. Daniel Sterman, the division director for ...

Detecting Evidence of Lung Cancer in Exhaled Breath Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ...

Christy Fischer has never felt lost or sorry for herself during the 18 years since her diagnosis with stage IV lung cancer.

Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition ...